The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Cardiovascular Biology of the Incretin System
Open accessAbstract
Glucagon-like peptide-1 (GLP-1) is an incretin hormone that enhances glucose-stimulated insulin secretion and exerts direct and indirect actions on the cardiovascular system. GLP-1 and its related incretin hormone, glucose-dependent insulinotropic polypeptide, are rapidly inactivated by the enzyme dipeptidyl peptidase 4 (DPP-4), a key determinant of incretin bioactivity. Two classes of medications that enhance incretin action, GLP-1 receptor (GLP-1R) agonists and DPP-4 inhibitors, are used for the treatment of type 2 diabetes mellitus. We review herein the cardiovascular biology of GLP-1R agonists and DPP-4 inhibitors, including direct and indirect effects on cardiomyocytes, blood vessels, adipocytes, the control of blood pressure, and postprandial lipoprotein secretion. Both GLP-1R activation and DPP-4 inhibition exert multiple cardioprotective actions in preclinical models of cardiovascular dysfunction, and short-term studies in human subjects appear to demonstrate modest yet beneficial actions on cardiac function in subjects with ischemic heart disease. Incretin-based agents control body weight, improve glycemic control with a low risk of hypoglycemia, decrease blood pressure, inhibit the secretion of intestinal chylomicrons, and reduce inflammation in preclinical studies. Nevertheless, there is limited information on the cardiovascular actions of these agents in patients with diabetes and established cardiovascular disease. Hence, a more complete understanding of the cardiovascular risk to benefit ratio of incretin-based therapies will require completion of long-term cardiovascular outcome studies currently underway in patients with type 2 diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–228 of 228
Single Dose GLP-1-Tf Ameliorates Myocardial Ischemia/Reperfusion Injury
Matsubara, M., Kanemoto, S., Leshnower, B. G., Albone, E. F., Hinmon, R., Plappert, T. A., Gorman, J. H., & Gorman, R. C. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.03.016 · Cited by 54
Moilanen, A., Rysä, J., Mustonen, E., Serpi, R., Aro, J., Tokola, H., Leskinen, H. K., Manninen, A., Levijoki, J. M., Vuolteenaho, O. J., et al. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.958033 · Cited by 54
Ossum, A. M., van Deurs, U., Engstrøm, T., Jensen, J. S., & Treiman, M. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.06.004 · Cited by 53
EDWARDS, C. L., Edwards, A., & Bloom, S. R. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004059 · Cited by 53
Nathanson, D., Erdogdu, Ö., Pernow, J., Zhang, Q., & Nyström, T. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.07.003 · Cited by 51
Clinical use of liraglutide in type 2 diabetes and its effects on cardiovascular risk factors
Varanasi, A., Patel, P., Makdissi, A., Dhindsa, S., Chaudhuri, A., & Dandona, P. (2012) · Endocrine Practice · doi:10.4158/ep11169.or · Cited by 50
Gardiner, S. M., March, J. E., Kemp, P. A., & Bennett, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093104 · Cited by 50
Xiao, Y., Nikolskaya, A. V., Jaye, D. A., & Sigg, D. C. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-6 · Cited by 49
Tomás, E., Wood, J. A., Stanojevic, V., & Habener, J. F. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01316.x · Cited by 48
The effect of glucagon-like peptide-2 on arterial blood flow and cardiac parameters
Bremholm, L., Hornum, M., Andersen, U. B., & Holst, J. J. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.11.001 · Cited by 44
Pala, L., Pezzatini, A., Dicembrini, I., Ciani, S., Gelmini, S., Vannelli, B., Cresci, B., Mannucci, E., & Rotella, C. M. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0195-3 · Cited by 44
Long-term consequences of type 2 diabetes mellitus: economic impact on society and managed care.
Killilea, T. (2002) · PubMed · Cited by 43
Exenatide Improves Hypertension in a Rat Model of the Metabolic Syndrome
Laugero, K. D., Stonehouse, A. H., Guss, S., Landry, J., Vu, C., & Parkes, D. G. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0095 · Cited by 42
Rolin, B., Deacon, C. F., Carr, R. D., & Åhrén, B. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.05.013 · Cited by 37
Angelone, T., Filice, E., Quintieri, A. M., Imbrogno, S., Amodio, N., Pasqua, T., Pellegrino, D., Mulè, F., & Cerra, M. C. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.07.014 · Cited by 32
Parlevliet, E. T., der Elst, J. P. S.-V., Corssmit, E. P. M., Picha, K. M., O’Neil, K. T., Stojanovic-Susulic, V., Ort, T., Havekes, L. M., Romijn, J. A., & Pijl, H. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.144154 · Cited by 32
Ding, K.-H., Zhong, Q. P. W., & Isales, C. M. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00509.2002 · Cited by 30
Gardiner, S. M., March, J. E., Kemp, P. A., & Bennett, T. M. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.75 · Cited by 28
Hypothalamic Germinoma Masquerading as Superior Mesenteric Artery (Sma) Syndrome
Vethakkan, S. R., Venugopal, Y., Tan, A. T. B., Paramasivam, S. S., Ratnasingam, J., Razak, R. A., Alias, A., Kassim, F., & Choong, K. (2012) · Endocrine Practice · doi:10.4158/ep12218.cr · Cited by 27
Effects of neuropeptide Y on L‐type calcium current in guinea‐pig ventricular myocytes
Bryant, S. M., & Hart, G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15560.x · Cited by 25
Fonseca, V. A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.016 · Cited by 23
Gustavson, S. M., Chen, D., Somayaji, V. R., Hudson, K. J., Baltrukonis, D. J., Singh, J., Boyden, T. L., & Calle, R. A. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01479.x · Cited by 21
Palmieri, F. E., & Ward, P. E. (1989) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-9543-4_45 · Cited by 19
Jackson, E. K., Zhang, M., Liu, W., & Mi, Z. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.126847 · Cited by 19
GIP: No Longer the Neglected Incretin Twin?
Kulkarni, R. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001027 · Cited by 16
Effects of centrally injected GLP-1 in various experimental models of gastric mucosal damage
Işbil-Büyükcoşkun, N., & Süyen, G. G. (2004) · Peptides · doi:10.1016/j.peptides.2004.05.001 · Cited by 11
Cruze, C. A., Su, F., Limberg, B. J., Deutsch, A. J., Stoffolano, P., Dai, H. J., Buchanan, D. D., Yang, H. T., Terjung, R. L., Spruell, R. D., et al. (2006) · Peptides · doi:10.1016/j.peptides.2006.09.026 · Cited by 10
Wang, S., Xie, Y., Zhou, X., Sha, W.-W., Wang, W., Han, L., Jia-chi, W., & Demin, Y. (2010) · PubMed · Cited by 8
Cited by
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
White, W. B., Cannon, C. P., Heller, S. R., Nissen, S. E., Bergenstal, R. M., Bakris, G. L., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305889 · Cited by 2,502
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Self-citationPathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Pharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500
Self-citationLow Wang, C. C., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,155
Metadata
- Authors
- Ussher, J. R., & Drucker, D. J.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2012-02-08
- Volume
- 33
- Issue
- 2
- Pages
- 187-215
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2029071587
- Cited by
- 530
- References
- 228
- FWCI
- 59.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.